1.	LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) Phase: Phase IV Type: Treatment Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: 2006-003750-23, LINFOTARGAM, NCT00466258
2.	PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia Phase: Phase IV Type: Treatment Status: Completed Age: 15 and over Sponsor: Other Protocol IDs: LAL-RI/96, NCT00494897
3.	LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive Phase: Phase IV Type: Treatment Status: Completed Age: 65 and under Sponsor: Other Protocol IDs: LAL-Ph-2000, NCT00526305
4.	Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 0 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000064664, POG-9404, NCT01230983
5.	IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 65 and under Sponsor: Other Protocol IDs: 2005-0366, NCT00469144
6.	Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Gastric Adenocarcinoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8120
7.	Phase II Combination and Sequential Chemotherapy for Undifferentiated and Lymphoblastic Lymphoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-IM-8101
8.	Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Malignant Melanoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8118
9.	Phase II Chemotherapy with Bisantrene Hydrochloride for Advanced Hepatoma in Relapse Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8119
10.	Phase II Pilot Chemotherapy with Bisantrene Hydrochloride in Adults with Refractory Acute Leukemia Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: SWOG-8161
11.	Phase II Pilot Multi-Agent Chemotherapy with Adjuvant TBI in Patients with Group IV Rhabdomyosarcoma or Extraosseous Ewing's Tumor Phase: Phase II Type: Treatment Status: Closed Age: 2 to 18 Sponsor: NCI Protocol IDs: POG-8157
12.	ALL Adult Consortium Trial: Adult ALL Trial Phase: Phase II Type: Treatment Status: Closed Age: 18 to 50 Sponsor: Other Protocol IDs: 06-254, NCT00476190
13.	Phase I Pilot Study of Chemotherapy with IDR in Combination with VPL (VCR/PRED/L-ASP) as Induction, ARA-C/L-ASP as Rescue Reinduction (if Necessary), and VCR, MTX, L-ASP, ARA-C, DNM as Maintenance in Patients with Acute Lymphocytic Leukemia in First Marrow Relapse Phase: Phase I Type: Treatment Status: Closed Age: 1 to 21 Sponsor: NCI Protocol IDs: CCG-133F